Pearson’s sample–sample correlation analysis clearly showed a clear correlation (R2 > 0.90) between CD5-positive DLBCL cases; this group was found to be a much more uniform disease population than CD5-positive DLBCL (Additional file 2: Fig. S4, Additional file 3: Table S2). The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.